Skip to content

Clinical trials

Phase 3 Leukemia, Lymphocytic, Chronic, B-Cell trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 3 Country / region: Netherlands Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20081
20096
20131
20141
20151
20162
20182
20192
20231
20241
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting5
Recruiting4
Terminated2
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BeOne Medicines5
Hoffmann-La Roche5
European Organisation for Research and Treatment of Cancer - EORTC4
Acerta Pharma BV2
Celgene2
Janssen Research & Development, LLC2
Novartis Pharmaceuticals2
AbbVie1
AstraZeneca1
BeiGene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell27
Lymphoma, Follicular4
Neoplasms4
Recurrence4
Leukemia3
Leukemia, B-Cell3
Lymphoma, B-Cell, Marginal Zone3
Lymphoma, Large B-Cell, Diffuse3
Lymphoma, Mantle-Cell3
Lymphoma, Non-Hodgkin3

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.